atomicspvSign up

Cedar

Funding History

$0$800M$1.6B$2.4B$3.2B202020212022
Valuation by funding round
Series D · 03/2021$3.2B

About

Cedar is a New York-based healthcare financial engagement platform, founded in 2016 by Florian Otto and Arel Lidow, that helps hospitals, health systems, and medical groups simplify patient billing and payment. The company's software powers pre-visit and post-visit billing communications, payment processing, financing options, and Medicaid enrollment support, aiming to make healthcare costs more transparent and affordable for patients.

CEO
Florian Otto
Headquarters
New York, NY
Founded
2016
Website
https://www.cedar.com

Overview

Cedar is a New York-based healthcare financial engagement platform, founded in 2016 by Florian Otto and Arel Lidow, that helps hospitals, health systems, and medical groups simplify patient billing and payment. The company's software powers pre-visit and post-visit billing communications, payment processing, financing options, and Medicaid enrollment support, aiming to make healthcare costs more transparent and affordable for patients. Cedar's 2021 acquisition of OODA Health, a rival healthcare billing technology company, combined provider- and payer-side billing data onto one platform.

Since 2025, Cedar has layered agentic AI onto its billing platform through Kora, a voice and text AI agent that explains charges, verifies insurance, and resolves billing questions directly with patients. By mid-2026 Kora had handled hundreds of thousands of patient calls across ten provider organizations, and Cedar expanded the product into a broader Kora Platform spanning inbound and outbound voice, two-way texting, and integration with hospital contact centers and electronic health record systems.

Private securities are speculative, illiquid, and involve risk of complete loss of principal. You should be prepared to hold private securities for an extended period; there is no assurance of a secondary market, an IPO, or other liquidity event. You are fully responsible for conducting your own due diligence. Pricing is indicative — nothing here is an offer of securities.

For more information, view our disclosures.